AKI Risk in COVID-19 vs Flu Not Disproportionately Higher With RAASi Use
RAAS inhibitor use is not associated with a disproportionately higher risk for acute kidney injury in patients with COVID-19.
Source: empr.com
Stay updated with breaking news from Edwardd Siew. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RAAS inhibitor use is not associated with a disproportionately higher risk for acute kidney injury in patients with COVID-19.
RAAS inhibitor use is not associated with a disproportionately higher risk for acute kidney injury in patients with COVID-19.